Prof Safi Dokmak is an expert in Surgery at Beaujon Hospital (France). Safi Dokmak has authored 489 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 3 of them ongoing. SLR score: 1,321 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Safi Dokmak Beaujon Hospital France
1 321 ScienceLeadR Reputation 1321
Network Map

Surgery

Subspecialties: Oncology - Hepatology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2008 - 2026

Source: PubMed

Beaujon Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 489

Citations

Citations: 9 425 1st author: 96 Last author: 56 Unique author: 8


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Comparison of endoscopic and radiologic drainage for symptomatic postoperative pancreatic fistula-associated collections after distal pancreatectomy.
PMID 42864456 — drainage, stents, fistula, endoscopy, therapeutics, pancreatic fistula, pancreatectomy
Surg Endosc20260
Predictors of morbidity and oncological benefit after liver resection with vascular reconstruction: international collaborative study from expert centres.
PMID 42803787 — mortality, carcinoma, hepatocellular, hepatic veins, portal vein, liver, vena cava, inferior, operative time, transplants, morbidity, veins, cholangiocarcinoma, extrahepatic cholangiocarcinoma
BJS Open20260
Morphology-Based Surgery for Chronic Pancreatitis Across Europe: Toward the Next Generation of Unified Guidelines.
PMID 42693506 — mortality, pancreatitis, chronic, pain, pancreatitis, morbidity, general surgery, pancreatectomy
Ann Surg20260
Laparoscopic left pancreatectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy compared to open left pancreatectomy: a single-center retrospective study.
PMID 42627533 — retrospective studies, adenocarcinoma, chemoradiotherapy, therapeutics, pancreatectomy
Surg Endosc20260
International consensus on mesopancreas and total mesopancreas excision (MESODELPHI).
PMID 42436071 — liver diseases
HPB (Oxford)20263

Clinical Studies 13

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 9
Phase 2 3
Phase 3 1

By status:

Completed 7
Recruiting 2
Unknown 2
Active not recruiting 1
Not yet recruiting 1

By type:

Interventional 10
Observational 3

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 0
multicentric5to9 5
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
JAK1 inhibitor treatment of inflammatory liver adenomas
2023-505278-13-00 — estrogens, neoplasms, contraception, liver, adenoma, liver cell, histology, adenoma, therapeutics, male, women
Phase 2Active not recruiting2024
Pancreaticoduodenectomies With Complete Arterial Coverage by Retromesenteric Omentoplasty
NCT05992857 — bile, fistula, gallbladder, bile ducts, surgical procedures, operative, pancreaticoduodenectomy, pancreaticojejunostomy, common bile duct, arteries, duodenum, pancreatic fistula, pancreatectomy
N/ARecruiting2024
Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma
NCT05971628 — liver transplantation, carcinoma, hepatocellular, liver, hepatectomy, transplantation, carcinoma
N/ANot yet recruiting2023

LeadR Networks

Main global connection map